Lördag 28 Mars | 22:56:47 Europe / Stockholm
Svenska | English

BioStock

Prenumeration

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

FluoGuide receives FDA Fast Track designation for FG001 in high-grade glioma
2026-03-20 08:43:00

FluoGuide has been granted Fast Track designation by FDA for its intraoperative imaging agent FG001. The designation applies to the surgical resection of high-grade glioma, a severe brain cancer with a high unmet medical need. This regulatory milestone follows the recent clearance of the company's Investigational New Drug application and provides opportunities for expedited review. BioStock contacted CEO Morten Albrechtsen to learn more.

Read the full article at biostock.se:
https://biostock.se/en/2026/03/fluoguide-erhaller-fda-fast-track-status-for-fg001-vid-hoggradigt-gliom/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter 
Follow BioStock on social media: LinkedIn and Facebook!  
 
About BioStock 
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.  
BioStock – Connecting Innovation & Capital. 

Källa MFN
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden